science top stories popular news  

Daily non-political popular news in brief.

U-M study offers new perspective on nitric oxide signaling in rheumatoid arthritis

10-30-2006 · EurekAlert!

Scientists at the University of Michigan Medical School have found evidence that challenges current thinking about the cause of rheumatoid arthritis, a chronic inflammatory disease that damages joints, causes pain, loss of movement and bone deformities in 2.1 million Americans

Read more »

Keywords: u-m, study, offers, perspective, nitric, oxide, signaling, rheumatoid, arthritis, offer, arthriti

« Previous | Next »

Similar news on "U-M study offers new perspective on nitric oxide signaling in rheumatoid arthritis":

  1. Enbrel safety data for up to 8 years in patients with juvenile rheumatoid arthritis
    06-13-2007 · EurekAlert!
    Amgen and Wyeth Pharmaceuticals, a division of Wyeth, today announced the presentation of additional data that showed that the safety profile of Enbrel was maintained with long-term use in patients with moderate-to-severe juvenile rheumatoid arthritis who completed up to eight years of therapy. The study results will be presented at the European League Against Rheumatism Annual Congress, an international rheumatology meeting, in Barcelona, Spain.
    Similar news · Read more »
  2. Preclinical study links gene to brain aneurysm formation
    08-07-2007 · EurekAlert!
    University of Cincinnati neurovascular researchers have identified a gene that -- when suppressed or completely absent -- may predispose a person to brain aneurysms. Todd Abruzzo, MD, and his colleagues demonstrated that "knocking out" a gene known as endothelial nitric oxide synthase in an animal model led to intracranial aneurysm formation in 33 percent of study subjects. Scientists say this suggests that the gene may play an important role in the development of intracranial aneurysms.
    Similar news · Read more »
  3. Cancer Drug May Be Remedy For Rheumatoid Arthritis, Study Finds
    09-30-2006 · ScienceDaily
    The potent cancer drug Gleevec, used to combat leukemia and some gastrointestinal cancers, may be useful in treating rheumatoid arthritis, according to a team of researchers at the Stanford University School of Medicine.
    Similar news · Read more »
  4. Blood clotting protein linked to rheumatoid arthritis
    11-16-2007 · EurekAlert!
    Researchers at Cincinnati Children's have issued the first study showing that a protein involved in blood clotting (fibrin), also plays an important role in the development of rheumatoid arthritis. Inflammatory joint disease appears to be driven by the engagement of inflammatory cells with fibrin matrices through a specific integrin receptor, aMD2. Researchers suggest that therapies designed to interrupt the localized interaction of inflammatory cells and fibrin may help arthritis patients.
    Similar news · Read more »
  5. New study reveals gender disparity in anti-TNF treatment for rheumatoid arthritis
    06-14-2007 · EurekAlert!
    Findings reported today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain, reveal a treatment disparity between female and male patients with rheumatoid arthritis. Data from a study at the Karolinska Institute, Sweden, show that women receive anti-TNFs -- very effective but expensive modern medications against this disease -- at a higher perceived level of disease activity, and when they are reporting more severe pain than their male counterparts.
    Similar news · Read more »
  6. Researchers identify genes that increase rheumatoid arthritis risk
    10-04-2007 · EurekAlert!
    Researchers in the United States and Sweden have identified a genetic region associated with increased risk of rheumatoid arthritis, a chronic and debilitating inflammatory disease of the joints that affects an estimated 2.1 million Americans. The US arm of the study involved a long-time collaboration between intramural researchers of the National Institute of Arthritis and Musculoskeletal and Skin Diseases and other organizations. NIAMS is one of 27 institutes and centers at the National Institutes of Health.
    Similar news · Read more »
  7. A daily dose of pistachios offers potential heart health benefits
    06-11-2007 · EurekAlert!
    Adding to a growing body of evidence, new research shows that a daily dose of pistachios may offer protective benefits against cardiovascular disease, according to a study published in the Volume 26, No. 2 issue of the Journal of the American College of Nutrition.
    Similar news · Read more »
  8. First prospective study shows improvement of rheumatoid arthritis during pregnancy
    06-14-2007 · EurekAlert!
    Disease activity in patients with rheumatoid arthritis is significantly reduced during pregnancy, according to new data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain. In the study, RA improved significantly from the first trimester to the third trimester of the participants' pregnancy and this effect extended into the postpartum stage.
    Similar news · Read more »
  9. Rheumatologists overestimate physical disability of rheumatoid arthritis patients
    06-28-2007 · EurekAlert!
    Rheumatologists substantially overestimate the physical disability of patients with rheumatoid arthritis, which may lead to inaccurate evaluations of patients' ability to work and need for lifestyle modifications, a new study found.
    Similar news · Read more »
  10. New study: pine bark extract boosts nitric oxide production
    10-17-2007 · EurekAlert!
    A study to be published in the October edition of Hypertension Research reveals Pycnogenol, an antioxidant plant extract from the bark of the French maritime pine tree, helps individuals by enhancing healthy nitric oxide production which leads to an increase in blood flow and oxygen supply to muscles.
    Similar news · Read more »